Jump to content

Recommended Posts

The 2016 Annual Meeting of the American Society of Clinical Oncologists (ASCO) will be held in Chicago from 3 - 7 June.


The New Prostate Cancer Infolink has a report on an abstract to be presented at ASCO about a phase II clinical trial of a new drug Ipataserib (GDC-0068) with Abiraterone in the treatment of metastatic castration-resistant prostate cancer.  Click on this link to read the report. 


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...